Perivascular fat, AMP-activated protein kinase and vascular diseases

British Journal of Pharmacology

Volumn 171, Issue 3, 2014, Pages 595-617

  Almabrouk, T A M ^a   Ewart, M A ^a   Salt, I P ^a   Kennedy, S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

adipocytes; adiponectin; AMP activated protein kinase; atherosclerosis; diabetes; hypertension; leptin; metformin; perivascular fat; vascular reactivity

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ADIPOCYTOKINE; ADIPONECTIN; APELIN; ATORVASTATIN; CHEMERIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; METFORMIN; MEVINOLIN; MICRORNA; MICRORNA 130B; MICRORNA 33A; MICRORNA 33B; MONOCYTE CHEMOTACTIC PROTEIN 1; NEFASTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; PIOGLITAZONE; RESISTIN; ROSIGLITAZONE; SIMVASTATIN; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASPIN;

ADIPOSE TISSUE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOCRINE EFFECT; AUTOPHAGY; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE REPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOLECULAR INTERACTION; MUSCLE CONTRACTILITY; NONHUMAN; OBESITY; PARACRINE SIGNALING; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASE; ATHEROSCLEROSIS; DIABETES; HYPERTENSION; LEPTIN; METFORMIN; PERIVASCULAR FAT; VASCULAR REACTIVITY;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ADIPOSITY; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AUTOCRINE COMMUNICATION; CARDIOVASCULAR AGENTS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME ACTIVATORS; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 84892422878     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12479     Document Type: Review

References (277)

1. Achike FI, To NH, Wang H, Kwan CY, (2011). Obesity, metabolic syndrome, adipocytes and vascular function: a holistic viewpoint. Clin Exp Pharmacol Physiol 38: 1-10.
2. Adams J, Chen ZP, Van Denderen BJ, Morton CJ, Parker MW, Witters LA, et al. (2004). Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Sci 13: 155-165.
3. Aki T, Funakoshi T, Unuma K, Uemura K, (2013). Impairment of autophagy: from hereditary disorder to drug intoxication. Toxicology 311: 205-215.
4. Alba G, El Bekay R, Alvarez-Maqueda M, Chacon P, Vega A, Monteseirin J, et al. (2004). Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils. FEBS Lett 573: 219-225.
5. Alexander SPH, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
6. Barnes BR, Ryder JW, Steiler TL, Fryer LG, Carling D, Zierath JR, (2002). Isoform-specific regulation of 5′ AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction. Diabetes 51: 2703-2708.
7. Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, et al. (2006). Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab 291: E843-E848.
8. Berg AH, Combs TP, Scherer PE, (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13: 84-89.
9. Bohlen F, Kratzsch J, Mueller M, Seidel B, Friedman-Einat M, Witzigmann H, et al. (2007). Leptin inhibits cell growth of human vascular smooth muscle cells. Vascul Pharmacol 46: 67-71.
10. Bosselaar M, Smits P, van Loon LJ, Tack CJ, (2011). Intravenous AICAR during hyperinsulinemia induces systemic hemodynamic changes but has no local metabolic effect. J Clin Pharmacol 51: 1449-1458.
11. Boyle JG, Logan PJ, Ewart MA, Reihill JA, Ritchie SA, Connell JM, et al. (2008). Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase. J Biol Chem 283: 11210-11217.
12. Boyle JG, Logan PJ, Jones GC, Small M, Sattar N, Connell JM, et al. (2011). AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia 54: 1799-1809.
13. Bradley EA, Eringa EC, Stehouwer CD, Korstjens I, van Nieuw Amerongen GP, Musters R, et al. (2010). Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion. Arterioscler Thromb Vasc Biol 30: 1137-1142.
14. Brian JE, Jr, Faraci FM, (1998). Tumor necrosis factor-alpha-induced dilatation of cerebral arterioles. Stroke 29: 509-515.
15. Buhl ES, Jessen N, Pold R, Ledet T, Flyvbjerg A, Pedersen SB, et al. (2002). Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51: 2199-2206.
16. Burns KA, Vanden Heuvel JP, (2007). Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta 1771: 952-960.
17. Bussey CT, Kolka CM, Rattigan S, Richards SM, (2011). Adiponectin opposes endothelin-1-mediated vasoconstriction in the perfused rat hindlimb. Am J Physiol Heart Circ Physiol 301: H79-H86.
18. Cahoon WD, Jr, Crouch MA, (2007). Preprocedural statin therapy in percutaneous coronary intervention. Ann Pharmacother 41: 1687-1693.
19. Cai XJ, Li CJ, Chen L, Rong YY, Zhang Y, Zhang M, (2008). A hypothesis: adiponectin mediates anti-atherosclerosis via adventitia-AMPK-iNOS pathway. Med Hypotheses 70: 1044-1047.
20. Cai XJ, Chen L, Li L, Feng M, Li X, Zhang K, et al. (2010). Adiponectin inhibits lipopolysaccharide-induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway. Mol Endocrinol 24: 218-228.
21. Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R, et al. (2008). Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 57: 696-705.
22. Cannon B, Nedergaard J, (2004). Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277-359.
23. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y, (2001). Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 98: 6390-6395.
24. Centeno-Baez C, Dallaire P, Marette A, (2011). Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1. Am J Physiol Endocrinol Metab 301: E922-E930.
25. Ceolotto G, Gallo A, Papparella I, Franco L, Murphy E, Iori E, et al. (2007). Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol 27: 2627-2633.
26. Cha HN, Choi JH, Kim YW, Kim JY, Ahn MW, Park SY, (2010). Metformin inhibits isoproterenol-induced cardiac hypertrophy in mice. Korean J Physiol Pharmacol 14: 377-384.
27. Chakrabarti P, English T, Karki S, Qiang L, Tao R, Kim J, et al. (2011). SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. J Lipid Res 52: 1693-1701.
28. Chang L, Villacorta L, Li R, Hamblin M, Xu W, Dou C, et al. (2012). Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-gamma deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 126: 1067-U1174.
29. Chang MY, Ho FM, Wang JS, Kang HC, Chang Y, Ye ZX, et al. (2010). AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway. Biochem Pharmacol 80: 1210-1220.
30. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, et al. (2009). Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 104: 541-549.
31. Chechi K, Blanchard PG, Mathieu P, Deshaies Y, Richard D, (2012). Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease. Int J Cardiol 167: 2264-2270.
32. Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O'Brien PE, Dixon JB, et al. (2005). Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90: 3665-3672.
33. Chen Y, Ohmori K, Mizukawa M, Yoshida J, Zeng Y, Zhang L, et al. (2007). Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes. Circ J 71: 144-152.
34. Chen Z, Peng IC, Sun W, Su MI, Hsu PH, Fu Y, et al. (2009). AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Circ Res 104: 496-505.
35. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D, (2000). Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 346 (Pt 3): 659-669.
36. Choi HC, Song P, Xie Z, Wu Y, Xu J, Zhang M, et al. (2008). Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo. J Biol Chem 283: 20186-20197.
37. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, et al. (2008). Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 118: 3343-3354.
38. Cinti S, (2005). The adipose organ. Prostaglandins Leukot Essent Fatty Acids 73: 9-15.
39. Cinti S, (2011). Between brown and white: novel aspects of adipocyte differentiation. Ann Med 43: 104-115.
40. Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, et al. (2006). Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3: 403-416.
41. Crute BE, Seefeld K, Gamble J, Kemp BE, Witters LA, (1998). Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J Biol Chem 273: 35347-35354.
42. Cuthbertson DJ, Babraj JA, Mustard KJ, Towler MC, Green KA, Wackerhage H, et al. (2007). 5-Aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. Diabetes 56: 2078-2084.
43. Dashwood MR, Dooley A, Shi-Wen X, Abraham DJ, Souza DS, (2007). Does periadventitial fat-derived nitric oxide play a role in improved saphenous vein graft patency in patients undergoing coronary artery bypass surgery. J Vasc Res 44: 175-181.
44. Daval M, Diot-Dupuy F, Bazin R, Hainault I, Viollet B, Vaulont S, et al. (2005). Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes. J Biol Chem 280: 25250-25257.
45. Davis BJ, Xie Z, Viollet B, Zou MH, (2006). Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 55: 496-505.
46. Deng G, Long Y, Yu YR, Li MR, (2010). Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS pathway. Int J Obes (Lond) 34: 165-171.
47. Digby JE, McNeill E, Dyar OJ, Lam V, Greaves DR, Choudhury RP, (2010). Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. Atherosclerosis 209: 89-95.
48. Dolinsky VW, Morton JS, Oka T, Robillard-Frayne I, Bagdan M, Lopaschuk GD, et al. (2010). Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat. Hypertension 56: 412-421.
49. Dong Y, Zhang M, Liang B, Xie Z, Zhao Z, Asfa S, et al. (2010a). Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 121: 792-803.
50. Dong Y, Zhang M, Wang S, Liang B, Zhao Z, Liu C, et al. (2010b). Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo. Diabetes 59: 1386-1396.
51. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, et al. (2008). Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8: 437-445.
52. Eiras S, Teijeira-Fernandez E, Shamagian LG, Fernandez AL, Vazquez-Boquete A, Gonzalez-Juanatey JR, (2008). Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine 43: 174-180.
53. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, et al. (2003). The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35: 807-825.
54. Eringa EC, Bakker W, Smulders YM, Serne EH, Yudkin JS, Stehouwer CD, (2007). Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 14: 389-402.
55. Ewart MA, Kennedy S, (2011). AMPK and vasculoprotection. Pharmacol Ther 131: 242-253.
56. Ewart MA, Kohlhaas CF, Salt IP, (2008). Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase. Arterioscler Thromb Vasc Biol 28: 2255-2257.
57. Fantuzzi G, (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919. quiz 920.
58. Fazakerley DJ, Holman GD, Marley A, James DE, Stockli J, Coster AC, (2010). Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes. J Biol Chem 285: 1653-1660.
59. Fernandez-Hernando C, Moore KJ, (2011). MicroRNA modulation of cholesterol homeostasis. Arterioscler Thromb Vasc Biol 31: 2378-2382.
60. Fésüs G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, Luft FC, et al. (2007). Adiponectin is a novel humoral vasodilator. Cardiovasc Res 75: 719-727.
61. Fischer M, Timper K, Radimerski T, Dembinski K, Frey DM, Zulewski H, et al. (2010). Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots. Diabetes Obes Metab 12: 356-359.
62. Fitzgibbons TP, Kogan S, Aouadi M, Hendricks GM, Straubhaar J, Czech MP, (2011). Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am J Physiol Heart Circ Physiol 301: H1425-H1437.
63. Flechtner-Mors M, Ditschuneit HH, Jenkinson CP, Alt A, Adler G, (1999). Metformin inhibits catecholamine-stimulated lipolysis in obese, hyperinsulinemic, hypertensive subjects in subcutaneous adipose tissue: an in situ microdialysis study. Diabet Med 16: 1000-1006.
64. Fogarty S, Hardie DG, (2009). C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest. J Biol Chem 284: 77-84.
65. Foley JM, Adams GR, Meyer RA, (1989). Utility of AICAr for metabolic studies is diminished by systemic effects in situ. Am J Physiol 257 (3 Pt 1): C488-C494.
66. Ford RJ, Teschke SR, Reid EB, Durham KK, Kroetsch JT, Rush JW, (2012). AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats. J Hypertens 30: 725-733.
67. Foretz M, Hebrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, et al. (2010). Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 120: 2355-2369.
68. Frontini A, Cinti S, (2010). Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab 11: 253-256.
69. Frontini A, Rousset S, Cassard-Doulcier AM, Zingaretti C, Ricquier D, Cinti S, (2007). Thymus uncoupling protein 1 is exclusive to typical brown adipocytes and is not found in thymocytes. J Histochem Cytochem 55: 183-189.
70. Fruhbeck G, (1999). Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48: 903-908.
71. Fryer LG, Foufelle F, Barnes K, Baldwin SA, Woods A, Carling D, (2002a). Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem J 363 (Pt 1): 167-174.
72. Fryer LG, Parbu-Patel A, Carling D, (2002b). The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232.
73. Fu YN, Xiao H, Ma XW, Jiang SY, Xu M, Zhang YY, (2011). Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation. Acta Pharmacol Sin 32: 879-887.
74. Fujita Y, Hosokawa M, Fujimoto S, Mukai E, Abudukadier A, Obara A, et al. (2010). Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice. Diabetologia 53: 1472-1481.
75. Fukada SY, Tirapelli CR, de Godoy MA, de Oliveira AM, (2005). Mechanisms underlying the endothelium-independent relaxation induced by angiotensin II in rat aorta. J Cardiovasc Pharmacol 45: 136-143.
76. Gaidhu MP, Fediuc S, Anthony NM, So M, Mirpourian M, Perry RL, et al. (2009). Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. J Lipid Res 50: 704-715.
77. Gaidhu MP, Perry RL, Noor F, Ceddia RB, (2010). Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes. Mol Endocrinol 24: 1434-1440.
78. Galassi A, Reynolds K, He J, (2006). Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119: 812-819.
79. Galic S, Fullerton MD, Schertzer JD, Sikkema S, Marcinko K, Walkley CR, et al. (2011). Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 121: 4903-4915.
80. Galvez B, de Castro J, Herold D, Dubrovska G, Arribas S, Gonzalez MC, et al. (2006). Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 26: 1297-1302.
81. Galvez-Prieto B, Bolbrinker J, Stucchi P, Heras AI, Merino B, Arribas S, et al. (2008). Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. J Endocrinol 197: 55-64.
82. Galvez-Prieto B, Somoza B, Gil-Ortega M, Garcia-Prieto CF, Heras AI, Gonzalez MC, et al. (2012). Anticontractile effect of perivascular adipose tissue and leptin are reduced in hypertension. Front Pharmacol 3: 103.
83. Gao YJ, Zeng ZH, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, et al. (2005). Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg 130: 1130-1136.
84. Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM, et al. (2006). Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 71: 363-373.
85. Gao YJ, Lu C, Su LY, Sharma AM, Lee RM, (2007). Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 151: 323-331.
86. Gauthier MS, Miyoshi H, Souza SC, Cacicedo JM, Saha AK, Greenberg AS, et al. (2008). AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J Biol Chem 283: 16514-16524.
87. Gauthier MS, O'Brien EL, Bigornia S, Mott M, Cacicedo JM, Xu XJ, et al. (2011). Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem Biophys Res Commun 404: 382-387.
88. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, et al. (2003). Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278: 34268-34276.
89. Goirand F, Solar M, Athea Y, Viollet B, Mateo P, Fortin D, et al. (2007). Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. J Physiol 581 (Pt 3): 1163-1171.
90. Gomez-Hernandez A, Otero YF, De las Heras N, Escribano O, Cachofeiro V, Lahera V, et al. (2012). Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction. Endocrinology 153: 1242-1255.
91. Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, et al. (2007). Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem 282: 32549-32560.
92. Gossl M, Herrmann J, Tang H, Versari D, Galili O, Mannheim D, et al. (2009). Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res Cardiol 104: 695-706.
93. Gu P, Xu A, (2013). Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 14: 49-58.
94. Guh JH, Chang WL, Yang J, Lee SL, Wei S, Wang D, et al. (2010). Development of novel adenosine monophosphate-activated protein kinase activators. J Med Chem 53: 2552-2561.
95. Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R, (2007). Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J Physiol Pharmacol 58: 591-610.
96. Hannan RE, Davis EA, Widdop RE, (2003). Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br J Pharmacol 140: 987-995.
97. Hansen JB, Kristiansen K, (2006). Regulatory circuits controlling white versus brown adipocyte differentiation. Biochem J 398: 153-168.
98. Hardie DG, (2007). AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8: 774-785.
99. Hardie DG, (2011). Adenosine monophosphate-activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection. Cold Spring Harb Symp Quant Biol 76: 155-164.
100. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, et al. (1996). Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879-27887.
101. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, et al. (2005). Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2: 9-19.
102. Hawley SA, Ross FA, Chevtzoff C, Green KA, Evans A, Fogarty S, et al. (2010). Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab 11: 554-565.
103. Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, et al. (2012). The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336: 918-922.
104. Hennig B, Chow CK, (1988). Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic Biol Med 4: 99-106.
105. Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, et al. (2005). Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25: 2594-2599.
106. Henry P, Thomas F, Benetos A, Guize L, (2002). Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension 40: 458-463.
107. Hermenegildo C, Oviedo PJ, Garcia-Perez MA, Tarin JJ, Cano A, (2005). Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells. J Pharmacol Exp Ther 315: 722-728.
108. Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, et al. (2003). Muscle-specific Pparg deletion causes insulin resistance. Nat Med 9: 1491-1497.
109. Huang F, Xiong X, Wang H, You S, Zeng H, (2010). Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kappaB. Acta Biochim Biophys Sin (Shanghai) 42: 325-331.
110. Ibe JC, Zhou Q, Chen T, Tang H, Yuan JX, Raj JU, et al. (2013). AMPK is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol 49: 609-618.
111. Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, et al. (2002). AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51: 2886-2894.
112. Jamaluddin MS, Weakley SM, Yao Q, Chen C, (2012). Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 165: 622-632.
113. Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston NR, et al. (2008). Vascular effects of apelin in vivo in man. J Am Coll Cardiol 52: 908-913.
114. Jeong HW, Hsu KC, Lee JW, Ham M, Huh JY, Shin HJ, et al. (2009). Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 296: E955-E964.
115. Kahn BB, Alquier T, Carling D, Hardie DG, (2005). AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25.
116. Kelly M, Keller C, Avilucea PR, Keller P, Luo Z, Xiang X, et al. (2004). AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun 320: 449-454.
117. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G, (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745-E751.
118. Ketonen J, Shi J, Martonen E, Mervaala E, (2010). Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 74: 1479-1487.
119. Kim HJ, Park KG, Yoo EK, Kim YH, Kim YN, Kim HS, et al. (2007). Effects of PGC-1alpha on TNF-alpha-induced MCP-1 and VCAM-1 expression and NF-kappaB activation in human aortic smooth muscle and endothelial cells. Am J Physiol Endocrinol Metab 9: 301-307.
120. Kim SA, Choi HC, (2012). Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells. Biochem Biophys Res Commun 425: 866-872.
121. Ko HJ, Zhang Z, Jung DY, Jun JY, Ma Z, Jones KE, et al. (2009). Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart. Diabetes 58: 2536-2546.
122. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, et al. (2004). Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94: e27-e31.
123. Koh HJ, Hirshman MF, He H, Li Y, Manabe Y, Balschi JA, et al. (2007). Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes. Biochem J 403: 473-481.
124. Kohlstedt K, Trouvain C, Boettger T, Shi L, Fisslthaler B, Fleming I, (2013). AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145. Circ Res 112: 1150-1158.
125. Kramer HF, Witczak CA, Fujii N, Jessen N, Taylor EB, Arnolds DE, et al. (2006). Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55: 2067-2076.
126. Kwon HM, Sangiorgi G, Ritman EL, Lerman A, McKenna C, Virmani R, et al. (1998). Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol 32: 2079.
127. Lamers D, Schlich R, Greulich S, Sasson S, Sell H, Eckel J, (2011). Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells. J Cell Mol Med 15: 1177-1188.
128. Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dirnagl U, et al. (2000). Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31: 2442-2449.
129. Laufs U, Gertz K, Dirnagl U, Bohm M, Nickenig G, Endres M, (2002). Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 942: 23-30.
130. LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, et al. (2006). Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab 291: E175-E181.
131. Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK, (2013). Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62: 194-204.
132. Lee RM, Lu C, Su LY, Gao YJ, (2009a). Endothelium-dependent relaxation factor released by perivascular adipose tissue. J Hypertens 27: 782-790.
133. Lee RM, Lu C, Su LY, Werstuck G, Gao YJ, (2009b). Effects of hyperglycemia on the modulation of vascular function by perivascular adipose tissue. J Hypertens 27: 118-131.
134. Lee YC, Chang HH, Chiang CL, Liu CH, Yeh JI, Chen MF, et al. (2011). Role of perivascular adipose tissue-derived methyl palmitate in vascular tone regulation and pathogenesis of hypertension. Circulation 124: 1160-1171.
135. Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS, (2010). Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 210: 656-661.
136. Li D, Wang D, Wang Y, Ling W, Feng X, Xia M, (2010a). Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice. J Biol Chem 285: 33499-33509.
137. Li D, Zhang Y, Ma J, Ling W, Xia M, (2010b). Adenosine monophosphate activated protein kinase regulates ABCG1-mediated oxysterol efflux from endothelial cells and protects against hypercholesterolemia-induced endothelial dysfunction. Arterioscler Thromb Vasc Biol 30: 1354-1362.
138. Li FY, Lam KS, Tse HF, Chen C, Wang Y, Vanhoutte PM, et al. (2012). Endothelium-selective activation of AMP-activated protein kinase prevents diabetes mellitus-induced impairment in vascular function and re-endothelialization via induction of heme oxygenase-1 in mice. Circulation 126: 1267-1277.
139. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, et al. (2012). Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 15: 545-553.
140. Lihn AS, Jessen N, Pedersen SB, Lund S, Richelsen B, (2004). AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem Biophys Res Commun 316: 853-858.
141. Lihn AS, Pedersen SB, Lund S, Richelsen B, (2008). The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Mol Cell Endocrinol 292: 36-41.
142. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM, (2000). Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6: 998-1003.
143. Liu Y, Wan Q, Guan Q, Gao L, Zhao J, (2006). High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle. Biochem Biophys Res Commun 339: 701-707.
144. Lu C, Su LY, Lee RM, Gao YJ, (2010). Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur J Pharmacol 634: 107-112.
145. Lu C, Su LY, Lee RM, Gao YJ, (2011). Alterations in perivascular adipose tissue structure and function in hypertension. Eur J Pharmacol 656: 68-73.
146. Luo S, Lei H, Liu Q, (2013). Correlation between serum adiponectin and risk factors in patients with coronary artery disease. Clin Lab 59: 121-126.
147. Ma GE, Liu P, Lei H, Chen J, Liu ZJ, (2010a). [Effect of liposuction on adipokines, inflammatory markers and insulin resistance]. Zhonghua Zheng Xing Wai Ke Za 26: 26-28.
148. Ma L, Ma S, He H, Yang D, Chen X, Luo Z, et al. (2010b). Perivascular fat-mediated vascular dysfunction and remodeling through the AMPK/mTOR pathway in high-fat diet-induced obese rats. Hypertens Res 33: 446-453.
149. Madan M, Bishayi B, Hoge M, Amar S, (2008). Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model. Atherosclerosis 197: 504-514.
150. Majithiya JB, Balaraman R, (2006). Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci 78: 2615-2624.
151. Mangano DT, (1997). Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. JAMA 277: 325-332.
152. Marchesi C, Ebrahimian T, Angulo O, Paradis P, Schiffrin EL, (2009). Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension 54: 1384-1392.
153. Mariman EC, Wang P, (2010). Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci 67: 1277-1292.
154. Marx N, Duez H, Fruchart JC, Staels B, (2004). Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 94: 1168-1178.
155. Mattu HS, Randeva HS, (2013). Role of adipokines in cardiovascular disease. J Endocrinol 216: T17-T36.
156. Medina-Ramon M, Schwartz J, (2007). Temperature, temperature extremes, and mortality: a study of acclimatisation and effect modification in 50 US cities. J Occup Environ Med 64: 827-833.
157. Meijer RI, Serne EH, Smulders YM, van Hinsbergh VW, Yudkin JS, Eringa EC, (2011). Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep 11: 211-217.
158. Meijer RI, Bakker W, Alta CL, Sipkema P, Yudkin JS, Viollet B, et al. (2013). Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes 62: 590-598.
159. Merrill GF, Kurth EJ, Hardie DG, Winder WW, (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273 (6 Pt 1): E1107-E1112.
160. Miao CY, Li ZY, (2012). The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol 165: 643-658.
161. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, et al. (2002). Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343.
162. Momcilovic M, Hong SP, Carlson M, (2006). Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281: 25336-25343.
163. Musi N, Goodyear LJ, (2002). Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2: 119-127.
164. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, et al. (2002). Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51: 2074-2081.
165. Nagata D, Hirata Y, (2010). The role of AMP-activated protein kinase in the cardiovascular system. Hypertens Res 33: 22-28.
166. Nakagawa K, Higashi Y, Sasaki S, Oshima T, Matsuura H, Chayama K, (2002). Leptin causes vasodilation in humans. Hypertens Res 25: 161-165.
167. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, et al. (2006). Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281: 2654-2660.
168. Nedergaard J, Bengtsson T, Cannon B, (2007). Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293: E444-E452.
169. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, et al. (2005). Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352: 29-38.
170. O'Toole TE, Conklin DJ, Bhatnagar A, (2008). Environmental risk factors for heart disease. Rev Environ Health 23: 167-202.
171. Oda A, Taniguchi T, Yokoyama M, (2001). Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 47: 141-150.
172. Ohman MK, Luo W, Wang H, Guo C, Abdallah W, Russo HM, et al. (2011). Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis 219: 33-39.
173. Okamoto E, Couse T, De Leon H, Vinten-Johansen J, Goodman RB, Scott NA, et al. (2001). Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 104: 2228-2235.
174. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476.
175. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al. (2004). Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309.
176. Papandreou I, Lim AL, Laderoute K, Denko NC, (2008). Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death Differ 15: 1572-1581.
177. Payne GA, Borbouse L, Kumar S, Neeb Z, Alloosh M, Sturek M, et al. (2010). Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-beta pathway. Arterioscler Thromb Vasc Biol 30: 1711-1717.
178. Phalitakul S, Okada M, Hara Y, Yamawaki H, (2012). A novel adipocytokine, vaspin inhibits platelet-derived growth factor-BB-induced migration of vascular smooth muscle cells. Biochem Biophys Res Commun 423: 844-849.
179. Pilon G, Dallaire P, Marette A, (2004). Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. J Biol Chem 279: 20767-20774.
180. Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, Flyvbjerg A, et al. (2005). Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54: 928-934.
181. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, et al. (2003). AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol 13: 867-871.
182. Polikandriotis JA, Mazzella LJ, Rupnow HL, Hart CM, (2005). Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. Arterioscler Thromb Vasc Biol 25: 1810-1816.
183. Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, Weintraub NL, (2010). Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol 10: 191-196.
184. Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, et al. (2010). Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 151: 3169-3180.
185. Rebolledo A, Rebolledo OR, Marra CA, Garcia ME, Roldan Palomo AR, Rimorini L, et al. (2010). Early alterations in vascular contractility associated to changes in fatty acid composition and oxidative stress markers in perivascular adipose tissue. Cardiovasc Diabetol 9: 65.
186. Riek U, Scholz R, Konarev P, Rufer A, Suter M, Nazabal A, et al. (2008). Structural properties of AMP-activated protein kinase: dimerization, molecular shape, and changes upon ligand binding. J Biol Chem 283: 18331-18343.
187. Rittig K, Dolderer JH, Balletshofer B, Machann J, Schick F, Meile T, et al. (2012). The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia 55: 1514-1525.
188. Rivera L, Moron R, Zarzuelo A, Galisteo M, (2009). Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77: 1053-1063.
189. Rocha VZ, Libby P, (2009). Obesity. Inflammation 6: 399-409.
190. Rodriguez A, Fortuno A, Gomez-Ambrosi J, Zalba G, Diez J, Fruhbeck G, (2007). The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 148: 324-331.
191. Ross R, (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
192. Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F, et al. (2009). Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab 94: 3611-3615.
193. Sag D, Carling D, Stout RD, Suttles J, (2008). Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 181: 8633-8641.
194. Sahin AS, Bariskaner H, (2007). The mechanisms of vasorelaxant effect of leptin on isolated rabbit aorta. Fundam Clin Pharmacol 21: 595-600.
195. Salabei JK, Cummins TD, Singh M, Jones SP, Bhatnagar A, Hill BG, (2013). PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J 451: 375-388.
196. Salcedo A, Garijo J, Monge L, Fernandez N, Luis Garcia-Villalon A, Sanchez Turrion V, et al. (2007a). Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids. Regul Pept 144: 50-55.
197. Salcedo A, Garijo J, Monge L, Sanchez A, Fernandez N, Garcia-Villalon AL, et al. (2007b). Endothelium-dependent relaxation of isolated splanchnic arteries from cirrhotic patients: role of reactive oxygen species. Hepatol Res 37: 811-819.
198. Salisbury E, Hipp J, Olmsted-Davis EA, Davis AR, Heggeness MH, Gannon FH, (2012). Histologic identification of brown adipose and peripheral nerve involvement in human atherosclerotic vessels. Hum Pathol 43: 2213-2222.
199. Salminen A, Hyttinen JM, Kaarniranta K, (2011). AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J Mol Med 89: 667-676.
200. Salt IP, Connell JM, Gould GW, (2000). 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49: 1649-1656.
201. Sanders MJ, Ali ZS, Hegarty BD, Heath R, Snowden MA, Carling D, (2007). Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J Biol Chem 282: 32539-32548.
202. Schleifenbaum J, Kohn C, Voblova N, Dubrovska G, Zavarirskaya O, Gloe T, et al. (2010). Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide. J Hypertens 28: 1875-1882.
203. Scott JW, Hawley SA, Green KA, Anis M, Stewart G, Scullion GA, et al. (2004). CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 113: 274-284.
204. Scott JW, van Denderen BJ, Jorgensen SB, Honeyman JE, Steinberg GR, Oakhill JS, et al. (2008). Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem Biol 15: 1220-1230.
205. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, et al. (1996). Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93: 2178-2187.
206. Semple RK, Chatterjee VK, O'Rahilly S, (2006). PPAR gamma and human metabolic disease. J Clin Invest 116: 581-589.
207. Shan J, Nguyen TB, Totary-Jain H, Dansky H, Marx SO, Marks AR, (2008). Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proc Natl Acad Sci U S A 105: 19006-19011.
208. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, et al. (2005). The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642-1646.
209. Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP, et al. (2008). Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther 83: 273-280.
210. Shyu KG, Lien LM, Wang BW, Kuan P, Chang H, (2011). Resistin contributes to neointimal formation via oxidative stress after vascular injury. Clin Sci (Lond) 120: 121-129.
211. Silaghi A, Achard V, Paulmyer-Lacroix O, Scridon T, Tassistro V, Duncea I, et al. (2007). Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status. Am J Physiol Endocrinol Metab 293: E1443-E1450.
212. Skilton MR, Serusclat A, Sethu AH, Brun S, Bernard S, Balkau B, et al. (2009). Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness. JACC. Cardiovasc Imaging 2: 176-182.
213. Soares de Moura R, Resende AC, Emiliano AF, Tano T, Mendes-Ribeiro AC, Correia ML, et al. (2004). The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br J Pharmacol 141: 860-866.
214. Soltis EE, Cassis LA, (1991). Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 13: 277-296.
215. Song P, Wang S, He C, Liang B, Viollet B, Zou MH, (2011). AMPKalpha2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells. Circ Res 109: 1230-1239.
216. Stastny J, Bienertova-Vasku J, Vasku A, (2012). Visfatin and its role in obesity development. Diabetes Metab Syndr 6: 120-124.
217. Stocker DJ, Taylor AJ, Langley RW, Jezior MR, Vigersky RA, (2007). A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes. Am Heart J 153: 445. e441-446.
218. Stone JD, Narine A, Shaver PR, Fox JC, Vuncannon JR, Tulis D, (2012). AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury. Am J Physiol Heart Circ Physiol 304: H369-381.
219. Sun W, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, et al. (2006). Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114: 2655-2662.
220. Szasz T, Webb RC, (2012). Perivascular adipose tissue: more than just structural support. Clin Sci (Lond) 122: 1-12.
221. Szasz T, Bomfim GF, Webb RC, (2013). The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag 9: 105-116.
222. Takaoka M, Suzuki H, Shioda S, Sekikawa K, Saito Y, Nagai R, et al. (2010). Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler Thromb Vasc Biol 30: 1576-1582.
223. Takeda-Watanabe A, Kitada M, Kanasaki K, Koya D, (2012). SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells. Biochem Biophys Res Commun 427: 191-196.
224. Takemori K, Gao YJ, Ding L, Lu C, Su LY, An WS, et al. (2007). Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 49: 365-372.
225. Tan BK, Adya R, Randeva HS, (2010). Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 20: 143-148.
226. Thalmann S, Meier CA, (2007). Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res 75: 690-701.
227. Tilg H, Moschen AR, (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783.
228. Tirapelli CR, Fukada SY, de Godoy MA, de Oliveira AM, (2006). Analysis of the mechanisms underlying the vasorelaxant action of angiotensin II in the isolated rat carotid. Life Sci 78: 2676-2682.
229. Trayhurn P, (2005). Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184: 285-293.
230. Trujillo ME, Scherer PE, (2006). Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27: 762-778.
231. Tsoyi K, Jang HJ, Nizamutdinova IT, Kim YM, Lee YS, Kim HJ, et al. (2011). Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. Br J Pharmacol 162: 1498-1508.
232. Turczynska KM, Bhattachariya A, Sall J, Goransson O, Sward K, Hellstrand P, et al. (2013). Stretch-sensitive down-regulation of the miR-144/451 cluster in vascular smooth muscle and its role in AMP-activated protein kinase signaling. PLoS ONE 8: e65135.
233. Uemura Y, Shibata R, Ohashi K, Enomoto T, Kambara T, Yamamoto T, et al. (2013). Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. FASEB J 27: 25-33.
234. Vigetti D, Clerici M, Deleonibus S, Karousou E, Viola M, Moretto P, et al. (2011). Hyaluronan synthesis is inhibited by adenosine monophosphate- activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells. J Biol Chem 286: 7917-7924.
235. Villena JA, Viollet B, Andreelli F, Kahn A, Vaulont S, Sul HS, (2004). Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. Diabetes 53: 2242-2249.
236. Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, et al. (2009). AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol 196: 81-98.
237. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, et al. (2002). Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79.
238. Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY, (2009a). Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 81: 370-380.
239. Wang S, Xu J, Song P, Viollet B, Zou MH, (2009b). In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I. Diabetes 58: 1893-1901.
240. Wang S, Zhang M, Liang B, Xu J, Xie Z, Liu C, et al. (2010). AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res 106: 1117-1128.
241. Wang SJ, Bo QY, Zhao XH, Yang X, Chi ZF, Liu XW, (2013). Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling. Brain Res 1492: 122-129.
242. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, et al. (2005). Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280: 18341-18347.
243. Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ, (1995). The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 359: 133-136.
244. Wei Z, Peterson JM, Lei X, Cebotaru L, Wolfgang MJ, Baldeviano GC, et al. (2012). C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. J Biol Chem 287: 10301-10315.
245. Weston AH, Egner I, Porter EL, Dong Y, Heagerty AM, Edwards G, (2013). Stimulated release of a hyperpolarising factor (ADHF) from rat mesenteric artery perivascular adipose tissue; involvement of myocyte BK channels. Br J Pharmacol 169: 1500-1509.
246. Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J, (2001). Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann N Y Acad Sci 947: 68-90. dicussion 90-62.
247. Wojcicka G, Jamroz-Wisniewska A, Atanasova P, Chaldakov GN, Chylinska-Kula B, Beltowski J, (2011). Differential effects of statins on endogenous H2S formation in perivascular adipose tissue. Pharmacol Res 63: 68-76.
248. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H, (2004). Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323: 630-635.
249. Wong KA, Lodish HF, (2006). A revised model for AMP-activated protein kinase structure: the alpha-subunit binds to both the beta- and gamma-subunits although there is no direct binding between the beta- and gamma-subunits. J Biol Chem 281: 36434-36442.
250. Wood IS, Trayhurn P, (2006). Adipokines and the signaling role of adipose tissue in inflammation and obesity. Future Lipidol 1: 81-89.
251. Woods A, Salt I, Scott J, Hardie DG, Carling D, (1996). The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397: 347-351.
252. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ, (2003). Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52: 1355-1363.
253. Xenos ES, Stevens SL, Freeman MB, Cassada DC, Goldman MH, (2005). Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells. Ann Vasc Surg 19: 386-392.
254. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, et al. (2011). Structure of mammalian AMPK and its regulation by ADP. Nature 472: 230-233.
255. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, et al. (2006). A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A 103: 17378-17383.
256. Xie Z, Dong Y, Scholz R, Neumann D, Zou MH, (2008). Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. Circulation 117: 952-962.
257. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
258. Yamawaki H, Hara N, Okada M, Hara Y, (2009). Visfatin causes endothelium-dependent relaxation in isolated blood vessels. Biochem Biophys Res Commun 383: 503-508.
259. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y, (2011). Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 408: 339-343.
260. Yamawaki H, Kameshima S, Usui T, Okada M, Hara Y, (2012a). A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochem Biophys Res Commun 423: 152-157.
261. Yamawaki H, Takahashi M, Mukohda M, Morita T, Okada M, Hara Y, (2012b). A novel adipocytokine, nesfatin-1 modulates peripheral arterial contractility and blood pressure in rats. Biochem Biophys Res Commun 418: 676-681.
262. Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I, (2007). Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physio 292: L567-L576.
263. Yang Z, Kahn BB, Shi H, Xue BZ, (2010). Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem 285: 19051-19059.
264. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, et al. (2008). Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57: 372-377.
265. Young LH, Li J, Baron SJ, Russell RR, (2005). AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 15: 110-118.
266. Yudkin JS, Eringa E, Stehouwer CD, (2005). 'Vasocrine' signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365: 1817-1820.
267. Zang M, Zuccollo A, Hou X, Nagata D, Walsh K, Herscovitz H, et al. (2004). AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279: 47898-47905.
268. Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong ZJ, Chen BL, et al. (2011). Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. Clin Exp Pharmacol Physiol 38: 55-62.
269. Zhang H, Zhang C, (2009b). Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of an adipose-vascular loop. Am J Biomed Sci 1: 133.
270. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, et al. (2009a). Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) 116: 219-230.
271. Zhang T, He J, Xu C, Zu L, Jiang H, Pu S, et al. (2009c). Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes. J Mol Endocrinol 42: 57-66.
272. Zhang Y, Lee TS, Kolb EM, Sun K, Lu X, Sladek FM, et al. (2006). AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 26: 1281-1287.
273. Zhao X, Zmijewski JW, Lorne E, Liu G, Park YJ, Tsuruta Y, et al. (2008). Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: L497-L504.
274. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
275. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A, (2008). Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 114: 361-374.
276. Zhuang G, Meng C, Guo X, Cheruku PS, Shi L, Xu H, et al. (2012). A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 125: 2892-2903.
277. Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WGT, Schlattner U, et al. (2004). Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem 279: 43940-43951.